MiR-205 impairs the autophagic flux and enhances cisplatin cytotoxicity in castration-resistant prostate cancer cells

Biochemical Pharmacology

Volumn 87, Issue 4, 2014, Pages 579-597

  Pennati, Marzia ^a   Lopergolo, Alessia ^a   Profumo, Valentina ^a   De Cesare, Michelandrea ^a   Sbarra, Stefania ^a   Valdagni, Riccardo ^a   Zaffaroni, Nadia ^a   Gandellini, Paolo ^a   Folini, Marco ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Autophagy; Cisplatin; LAMP3; miR 205; Prostate cancer; RAB27A

Indexed keywords

AUTOPHAGY; CISPLATIN; LAMP3; MIR-205; PROSTATE CANCER; RAB27A;

ANIMALS; ANTINEOPLASTIC AGENTS; AUTOPHAGY; CELL LINE, TUMOR; CISPLATIN; CYTOTOXINS; DRUG RESISTANCE, NEOPLASM; HUMANS; MALE; MICE; MICE, SCID; MICRORNAS; PROSTATIC NEOPLASMS;

EID: 84893731055     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.12.009     Document Type: Article

References (53)

1. B. Seruga, A. Ocana, and I.F. Tannock Drug resistance in metastatic castration-resistant prostate cancer Nat Rev Clin Oncol 8 2010 12 23
2. J.S. de Bono, C.J. Logothetis, A. Molina, K. Fizazi, S. North, and L. Chu et al. Abiraterone and increased survival in metastatic prostate cancer N Engl J Med 364 2011 1995 2005
3. H.I. Scher, K. Fizazi, F. Saad, M.E. Taplin, C.N. Sternberg, and K. Miller et al. Increased survival with enzalutamide in prostate cancer after chemotherapy N Engl J Med 367 2012 1187 1197
4. H. Sheikh, J. Abdulghani, S. Ali, R. Sinha, and A. Lipton Impact of genetic targets on prostate cancer therapy Adv Exp Med Biol 779 2013 359 383
5. P. Gandellini, V. Profumo, M. Folini, and N. Zaffaroni MicroRNAs as new therapeutic targets and tools in cancer Expert Opin Ther Targets 15 2011 265 279
6. S.P. Nana-Sinkam, and C.M. Croce Clinical applications for microRNAs in cancer Clin Pharmacol Ther 93 2013 98 104
7. P. Gandellini, M. Folini, N. Longoni, M. Pennati, M. Binda, and M. Colecchia et al. miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon Cancer Res 69 2009 2287 2295
8. P. Gandellini, E. Giannoni, A. Casamichele, M.L. Taddei, M. Callari, and C. Piovan et al. miR-205 hinders the malignant interplay between prostate cancer cells and associated fibroblasts Antioxid Redox Signal 2013 10.1089/ars.2013.5292
9. P. Gandellini, V. Profumo, A. Casamichele, N. Fenderico, S. Borrelli, and G. Petrovich et al. miR-205 regulates basement membrane deposition in human prostate: implications for cancer development Cell Death Differ 19 2012 1750 1760
10. A. Voulgari, and A. Pintzas Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic Biochim Biophys Acta 1796 2009 75 90
11. C.S. Matos, A.L. de Carvalho, R.P. Lopes, and M.P. Marques New strategies against prostate cancer - Pt(II)-based chemotherapy Curr Med Chem 19 2012 4678 4687
12. D.H. Kern, C.R. Morgan, and S.U. Hildebrand-Zanki In vitro pharmacodynamics of 1-β-d-arabinofuranosylcytosine: synergy of antitumor activity with cis-diamminedichloroplatinum(II) Cancer Res 48 1988 117 121 (Pubitemid 18030339)
13. Y. Kabeya, N. Mizushima, T. Ueno, A. Yamamoto, T. Kirisako, and T. Noda et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing EMBO J 19 2000 5720 5728
14. P. Du, W.A. Kibbe, and S.M. Lin lumi: a pipeline for processing Illumina microarray Bioinformatics 24 2008 1547 1548 (Pubitemid 351911712)
15. R.C. Gentleman, V.J. Carey, D.M. Bates, B. Bolstad, M. Dettling, and S. Dudoit et al. Bioconductor: open software development for computational biology and bioinformatics Genome Biol 5 2004 R80
16. C. Pisano, L. Vesci, R. Foderà, F.F. Ferrara, C. Rossi, and M. De Cesare et al. Antitumor activity of the combination of synthetic retinoid ST1926 and cisplatin in ovarian carcinoma models Ann Oncol 18 2007 1500 1505 (Pubitemid 47365482)
17. D.J. Klionsky, F.C. Abdalla, H. Abeliovich, R.T. Abraham, A. Acevedo-Arozena, and K. Adeli et al. Guidelines for the use and interpretation of assays for monitoring autophagy Autophagy 8 2012 445 544
18. W.W. Dong, Q. Mou, J. Chen, J.T. Cui, W.M. Li, and W.H. Xiao Differential expression of Rab27A/B correlates with clinical outcome in hepatocellular carcinoma World J Gastroenterol 18 2012 1806 1813
19. K. Ozaki, M. Nagata, M. Suzuki, T. Fujiwara, K. Ueda, and Y. Miyoshi et al. Isolation and characterization of a novel human lung-specific gene homologous to lysosomal membrane glycoproteins 1 and 2: significantly increased expression in cancers of various tissues Cancer Res 58 1998 3499 3503 (Pubitemid 28376538)
20. A. Nagelkerke, H. Mujcic, J. Bussink, B.G. Wouters, H.W. van Laarhoven, and F.C. Sweep et al. Hypoxic regulation and prognostic value of LAMP3 expression in breast cancer Cancer 117 2011 3670 3681
21. H. Kanao, T. Enomoto, T. Kimura, M. Fujita, R. Nakashima, and Y. Ueda et al. Overexpression of LAMP3/TSC403/DC-LAMP promotes metastasis in uterine cervical cancer Cancer Res 65 2005 8640 8645 (Pubitemid 41377350)
22. L. Galluzzi, L. Senovilla, I. Vitale, J. Michels, I. Martins, and O. Kepp et al. Molecular mechanisms of cisplatin resistance Oncogene 31 2012 1869 1883
23. B. Dave, V. Mittal, N.M. Tan, and J.C. Chang Epithelial-mesenchymal transition, cancer stem cells and treatment resistance Breast Cancer Res 14 2012 202
24. A. Latifi, K. Abubaker, N. Castrechini, A.C. Ward, C. Liongue, and F. Dobill et al. Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile J Cell Biochem 112 2011 2850 2864
25. T. Arumugam, V. Ramachandran, K.F. Fournier, H. Wang, L. Marquis, and J.L. Abbruzzese et al. Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer Cancer Res 69 2009 5820 5828
26. F. Meng, G. Sun, M. Zhong, Y. Yu, and M.A. Brewer Anticancer efficacy of cisplatin and trichostatin A or 5-aza-2′-deoxycytidine on ovarian cancer Br J Cancer 108 2013 579 586
27. M.P. Barr, S.G. Gray, A.C. Hoffmann, R.A. Hilger, J. Thomale, and J.D. O'Flaherty et al. Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature PLoS ONE 8 2013 e54193
28. M. Kurokawa, N. Ise, K. Omi, K. Goishi, and S. Higashiyama Cisplatin influences acquisition of resistance to molecular-targeted agents via epithelial-mesenchymal transition-like changes Cancer Sci 104 2013 904 911
29. Y. Wang, and Z.H. Qin Coordination of autophagy with other cellular activities Acta Pharmacol Sin 34 2013 585 594
30. L. Oliver, E. Hue, M. Priault, and F.M. Vallette Basal autophagy decreased during the differentiation of human adult mesenchymal stem cells Stem Cells Dev 21 2012 2779 2788
31. J. Li, B. Yang, Q. Zhou, Y. Wu, D. Shang, and Y. Guo et al. Autophagy promotes hepatocellular carcinoma cell invasion through activation of epithelial-mesenchymal transition Carcinogenesis 34 2013 1343 1351
32. Q. Lv, F. Hua, and Z.W. Hu DEDD, a novel tumor repressor, reverses epithelial-mesenchymal transition by activating selective autophagy Autophagy 8 2012 1675 1676
33. L.L. Fu, X. Wen, J.K. Bao, and B. Liu MicroRNA-modulated autophagic signaling networks in cancer Int J Biochem Cell Biol 44 2012 733 736
34. A. Strillacci, M.C. Valerii, P. Sansone, C. Caggiano, A. Sgromo, and L. Vittori et al. Loss of miR-101 expression promotes Wnt/β-catenin signalling pathway activation and malignancy in colon cancer cells J Pathol 229 2013 379 389
35. R. Kumarswamy, G. Mudduluru, P. Ceppi, S. Muppala, M. Kozlowski, and J. Niklinski et al. MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer Int J Cancer 130 2012 2044 2053
36. Y. Wang, W. Li, X. Zang, N. Chen, T. Liu, and P.A. Tsonis et al. MicroRNA-204-5p regulates epithelial-to-mesenchymal transition during human posterior capsule opacification by targeting SMAD4 Invest Ophthalmol Vis Sci 54 2013 323 332
37. U. Wellner, J. Schubert, U.C. Burk, O. Schmalhofer, F. Zhu, and A. Sonntag et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs Nat Cell Biol 11 2009 1487 1495
38. Z. Zou, L. Wu, H. Ding, Y. Wang, Y. Zhang, and X. Chen et al. MicroRNA-30a sensitizes tumor cells to cis-platinum via suppressing beclin 1-mediated autophagy J Biol Chem 287 2012 4148 4156
39. L. Sun, Y. Yao, B. Liu, Z. Lin, L. Lin, and M. Yang et al. MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1 Oncogene 31 2012 432 445
40. Y. Zhang, Y. Cheng, X. Ren, L. Zhang, K.L. Yap, and H. Wu et al. NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response Oncogene 31 2012 1055 1064
41. J.H. Ren, W.S. He, L. Nong, Q.Y. Zhu, K. Hu, and R.G. Zhang et al. Acquired cisplatin resistance in human lung adenocarcinoma cells is associated with enhanced autophagy Cancer Biother Radiopharm 25 2010 75 80
42. H. Yu, J. Su, Y. Xu, J. Kang, H. Li, and L. Zhang et al. p62/SQSTM1 involved in cisplatin resistance in human ovarian cancer cells by clearing ubiquitinated proteins Eur J Cancer 47 2011 1585 1594
43. J.S. Wang, F.B. Wang, Q.G. Zhang, Z.Z. Shen, and Z.M. Shao Enhanced expression of Rab27A gene by breast cancer cells promoting invasiveness and the metastasis potential by secretion of insulin-like growth factor-II Mol Cancer Res 6 2008 372 382
44. Y. Liu, Y. Zhou, and K. Zhu Inhibition of glioma cell lysosome exocytosis inhibits glioma invasion PLoS ONE 7 2012 e45910
45. I.A. Asangani, P.W. Harms, L. Dodson, M. Pandhi, L.P. Kunju, and C.A. Maher et al. Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma Oncotarget 3 2012 1011 1025
46. A. Bobrie, S. Krumeich, F. Reyal, C. Recchi, L.F. Moita, and M.C. Seabra et al. Rab27 a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression Cancer Res 72 2012 4920 4930
47. A. Nagelkerke, J. Bussink, H. Mujcic, B.G. Wouters, S. Lehmann, and F.C. Sweep et al. Hypoxia stimulates migration of breast cancer cells via the PERK/ATF4/LAMP3-arm of the unfolded protein response Breast Cancer Res 15 2013 R2
48. H. Mujcic, T. Rzymski, K.M. Rouschop, M. Koritzinsky, M. Milani, and A.L. Harris et al. Hypoxic activation of the unfolded protein response (UPR) induces expression of the metastasis-associated gene LAMP3 Radiother Oncol 92 2009 450 459
49. T. Igarashi, H. Izumi, T. Uchiumi, K. Nishio, T. Arao, and M. Tanabe et al. Clock and ATF4 transcription system regulates drug resistance in human cancer cell lines Oncogene 26 2007 4749 4760 (Pubitemid 47093179)
50. M. Tanabe, H. Izumi, T. Ise, S. Higuchi, T. Yamori, and K. Yasumoto et al. Activating transcription factor 4 increases the cisplatin resistance of human cancer cell lines Cancer Res 63 2003 8592 8595 (Pubitemid 38064031)
51. H.L. Janssen, H.W. Reesink, E.J. Lawitz, S. Zeuzem, M. Rodriguez-Torres, and K. Patel et al. Treatment of HCV infection by targeting microRNA N Engl J Med 368 2013 1685 1694
52. H. Dweep, C. Sticht, P. Pandey, and N. Gretz miRWalk - database: prediction of possible miRNA binding sites by walking the genes of 3 genomes J Biomed Inform 44 2011 839 847
53. A. Grimson, K. Kai-How Farh, W.K. Johnston, P. Garrett-Engele, L.P. Lim, and D.P. Bartel MicroRNA targeting specificity in mammals: determinants beyond seed pairing Mol Cell 27 2007 91 105 (Pubitemid 46991392)